Sort by
Refine Your Search
-
Listed
-
Category
-
Country
-
Employer
- University of North Carolina at Chapel Hill
- Indiana University
- Rutgers University
- THE UNIVERSITY OF HONG KONG
- University of Basel
- University of Florida
- University of Kansas Medical Center
- University of Minnesota
- Baylor College of Medicine
- Eli Lilly and Company
- Institute of Macromolecular Chemistry CAS
- Linköping University
- Lunenfeld-Tanenbaum Research Institute
- NEW YORK UNIVERSITY ABU DHABI
- Stanford University
- The Jackson Laboratory
- University of Copenhagen
- University of Utah
- University of Washington
- Università di Bologna
- Łukasiewicz Research Network - Krakow Institute of Technology
- 11 more »
- « less
-
Field
-
Department: SOM KC Internal Medicine - Endocrinology, Metabolism & Genetics ----- Medicine-Endocrine Metabolic Gene Position Title: Post Doctoral Fellow - Internal Medicine (Endocrinology, Diabetes
-
, type 2 diabetes and steatotic liver disease. The project of the successful candidate will focus on mitochondrial metabolism in macrophages of the liver using isotope tracing, flow cytometry, molecular
-
disease, Parkinson’s diseases and type II diabetes. Successful applicants will be highly motivated with an interest in working in the areas of Molecular Medicine and Chemical Biology, must hold a Ph.D
-
antagonism and develop peptide‑based inhibitors for diseases such as cancer and diabetic complications. Among the key duties of this position are the following: Performs independent research involving cell
-
conjugates designed for the treatment of type 2 diabetes. The successful candidate will conduct independent, conceptually-driven research in the field of novel conjugates that are capable of carrying and
-
Dr. Playdon’s research, visit her faculty profile https://profiles.faculty.utah.edu/u6017378 . Details about the NIH-funded project (1R01CA313949) can be found on NIH RePORTER: https://reporter.nih.gov
-
of phosphoinositide 3-kinase (PI3K) signaling in allergy, metabolic control, obesity, diabetes and cancer; see https://p3.snf.ch/project-189065 ii) developing and validation of novel chemical probes and degraders
-
program seeks to increase our understanding of the immunological and molecular mechanisms involved in autoimmune dysregulation in Type 1 diabetes (T1D). Through the use of novel murine models of T1D, human
-
goals, international candidates, women and candidates from all backgrounds. We truly believe in equal opportunity for all. For more information about the Jalili laboratory, please visit: https
-
Metabolism Group or Departmental Website: http://wenfei.org(link is external) Does this position pay above the required minimum?: Yes. The expected base pay range for this position is listed in Pay Range field